Indeed, FGF/FGFR blockade induced the rapid proteasomal degradation of c-Myc protein, as confirmed by pre-treatment of MM cells with the proteasome inhibitor MG132 that prevented c-Myc degradation upon FGF inhibition. Here, MYC is linked to Miyoshi myopathy.